Malignant hyperthermia causing Gly2435Arg mutation of the ryanodine receptor facilitates ryanodine-induced calcium release in myotubes
- PMID: 10700782
- DOI: 10.1093/bja/83.6.855
Malignant hyperthermia causing Gly2435Arg mutation of the ryanodine receptor facilitates ryanodine-induced calcium release in myotubes
Abstract
We have investigated if cultivated muscle cells from malignant hyperthermia (MH) patients can be distinguished pharmacologically from controls. Muscle specimens from four individuals carrying the Gly2435Arg mutation of the skeletal muscle ryanodine receptor protein (RYR1) and from four controls were used to culture myotubes. Resting intracellular calcium concentration ([Ca2+]i) of MH myotubes was similar to controls. However, when ryanodine 0.5 mumol litre-1 was added, the kinetics of the increase in the calcium signals in MH and control cells were significantly different; the time for half maximum increase was mean 197 (SD 131) s for MH cells and 474 (61) s for controls (n = 80 cells each). On average, the area under the MH response curves was twice the control value. These results give rise to hopes that the phenotype of MH can be characterized using cultured human muscle and that a culture-based test for MH susceptibility may eventually be developed.
Similar articles
-
Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR.Am J Physiol Cell Physiol. 2007 May;292(5):C1591-8. doi: 10.1152/ajpcell.00133.2006. Epub 2006 Dec 20. Am J Physiol Cell Physiol. 2007. PMID: 17182726
-
Phenotyping malignant hyperthermia susceptibility by measuring halothane-induced changes in myoplasmic calcium concentration in cultured human skeletal muscle cells.Br J Anaesth. 2002 Oct;89(4):571-9. doi: 10.1093/bja/aef237. Br J Anaesth. 2002. PMID: 12393358
-
Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect Of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors.J Clin Invest. 1998 Mar 15;101(6):1233-42. doi: 10.1172/JCI993. J Clin Invest. 1998. PMID: 9502764 Free PMC article.
-
Ryanodine receptor mutations in malignant hyperthermia and central core disease.Hum Mutat. 2000;15(5):410-7. doi: 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D. Hum Mutat. 2000. PMID: 10790202 Review.
-
Genetics of malignant hyperthermia.ScientificWorldJournal. 2006 Dec 28;6:1722-30. doi: 10.1100/tsw.2006.289. ScientificWorldJournal. 2006. PMID: 17195870 Free PMC article. Review.
Cited by
-
Exercise-induced rhabdomyolysis and stress-induced malignant hyperthermia events, association with malignant hyperthermia susceptibility, and RYR1 gene sequence variations.ScientificWorldJournal. 2013;2013:531465. doi: 10.1155/2013/531465. Epub 2013 Feb 10. ScientificWorldJournal. 2013. PMID: 23476141 Free PMC article. Review.
-
Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019.Orphanet J Rare Dis. 2020 May 7;15(1):113. doi: 10.1186/s13023-020-01384-x. Orphanet J Rare Dis. 2020. PMID: 32381029 Free PMC article.
-
RYR1 Sequence Variants in Myopathies: Expression and Functional Studies in Two Families.Biomed Res Int. 2019 Apr 21;2019:7638946. doi: 10.1155/2019/7638946. eCollection 2019. Biomed Res Int. 2019. PMID: 31165076 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous